BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Chambers AG, Percy AJ, Simon R, Borchers CH. MRM for the verification of cancer biomarker proteins: recent applications to human plasma and serum. Expert Rev Proteomics 2014;11:137-48. [PMID: 24476379 DOI: 10.1586/14789450.2014.877346] [Cited by in Crossref: 53] [Cited by in F6Publishing: 46] [Article Influence: 6.6] [Reference Citation Analysis]
Number Citing Articles
1 Zhang B, Whiteaker JR, Hoofnagle AN, Baird GS, Rodland KD, Paulovich AG. Clinical potential of mass spectrometry-based proteogenomics. Nat Rev Clin Oncol 2019;16:256-68. [PMID: 30487530 DOI: 10.1038/s41571-018-0135-7] [Cited by in Crossref: 67] [Cited by in F6Publishing: 61] [Article Influence: 22.3] [Reference Citation Analysis]
2 Kim KH, Kim JY, Yoo JS. Mass spectrometry analysis of glycoprotein biomarkers in human blood of hepatocellular carcinoma. Expert Review of Proteomics 2019;16:553-68. [DOI: 10.1080/14789450.2019.1626235] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
3 Hsiao YC, Chu LJ, Chen JT, Yeh TS, Yu JS. Proteomic profiling of the cancer cell secretome: informing clinical research. Expert Rev Proteomics 2017;14:737-56. [PMID: 28695748 DOI: 10.1080/14789450.2017.1353913] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.2] [Reference Citation Analysis]
4 Gianazza E, Tremoli E, Banfi C. The selected reaction monitoring/multiple reaction monitoring-based mass spectrometry approach for the accurate quantitation of proteins: clinical applications in the cardiovascular diseases. Expert Rev Proteomics 2014;11:771-88. [PMID: 25400095 DOI: 10.1586/14789450.2014.947966] [Cited by in Crossref: 25] [Cited by in F6Publishing: 21] [Article Influence: 3.1] [Reference Citation Analysis]
5 Jean Beltran PM, Federspiel JD, Sheng X, Cristea IM. Proteomics and integrative omic approaches for understanding host-pathogen interactions and infectious diseases. Mol Syst Biol 2017;13:922. [PMID: 28348067 DOI: 10.15252/msb.20167062] [Cited by in Crossref: 96] [Cited by in F6Publishing: 84] [Article Influence: 19.2] [Reference Citation Analysis]
6 Parker CE, Borchers CH. Mass spectrometry based biomarker discovery, verification, and validation--quality assurance and control of protein biomarker assays. Mol Oncol. 2014;8:840-858. [PMID: 24713096 DOI: 10.1016/j.molonc.2014.03.006] [Cited by in Crossref: 139] [Cited by in F6Publishing: 126] [Article Influence: 17.4] [Reference Citation Analysis]
7 Voinov VG, Bennett SE, Beckman JS, Barofsky DF. ECD of tyrosine phosphorylation in a triple quadrupole mass spectrometer with a radio-frequency-free electromagnetostatic cell. J Am Soc Mass Spectrom 2014;25:1730-8. [PMID: 25037842 DOI: 10.1007/s13361-014-0956-2] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
8 Oberbach A, Schlichting N, Neuhaus J, Kullnick Y, Lehmann S, Heinrich M, Dietrich A, Mohr FW, von Bergen M, Baumann S. Establishing a Reliable Multiple Reaction Monitoring-Based Method for the Quantification of Obesity-Associated Comorbidities in Serum and Adipose Tissue Requires Intensive Clinical Validation. J Proteome Res 2014;13:5784-800. [DOI: 10.1021/pr500722k] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
9 Hirtz C, Vialaret J, Nowak N, Gabelle A, Deville de Périère D, Lehmann S. Absolute quantification of 35 plasma biomarkers in human saliva using targeted MS. Bioanalysis 2016;8:43-53. [PMID: 26647646 DOI: 10.4155/bio.15.228] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
10 Cho WC. Proteomics in translational cancer research: biomarker discovery for clinical applications. Expert Rev Proteomics 2014;11:131-3. [PMID: 24646121 DOI: 10.1586/14789450.2014.899908] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 2.1] [Reference Citation Analysis]
11 Liu X, Zheng W, Wang W, Shen H, Liu L, Lou W, Wang X, Yang P. A new panel of pancreatic cancer biomarkers discovered using a mass spectrometry-based pipeline. Br J Cancer. 2017;117:1846-1854. [PMID: 29123261 DOI: 10.1038/bjc.2017.365] [Cited by in Crossref: 39] [Cited by in F6Publishing: 38] [Article Influence: 7.8] [Reference Citation Analysis]
12 Huang R, Chen Z, He L, He N, Xi Z, Li Z, Deng Y, Zeng X. Mass spectrometry-assisted gel-based proteomics in cancer biomarker discovery: approaches and application. Theranostics 2017;7:3559-72. [PMID: 28912895 DOI: 10.7150/thno.20797] [Cited by in Crossref: 24] [Cited by in F6Publishing: 22] [Article Influence: 4.8] [Reference Citation Analysis]
13 Whitham M, Febbraio MA. The ever-expanding myokinome: discovery challenges and therapeutic implications. Nat Rev Drug Discov 2016;15:719-29. [PMID: 27616294 DOI: 10.1038/nrd.2016.153] [Cited by in Crossref: 125] [Cited by in F6Publishing: 113] [Article Influence: 20.8] [Reference Citation Analysis]
14 Zhang Z, Wuhrer M, Holst S. Serum sialylation changes in cancer. Glycoconj J 2018;35:139-60. [PMID: 29680984 DOI: 10.1007/s10719-018-9820-0] [Cited by in Crossref: 56] [Cited by in F6Publishing: 53] [Article Influence: 14.0] [Reference Citation Analysis]
15 Thomas SN, Harlan R, Chen J, Aiyetan P, Liu Y, Sokoll LJ, Aebersold R, Chan DW, Zhang H. Multiplexed Targeted Mass Spectrometry-Based Assays for the Quantification of N-Linked Glycosite-Containing Peptides in Serum. Anal Chem 2015;87:10830-8. [PMID: 26451657 DOI: 10.1021/acs.analchem.5b02063] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 3.3] [Reference Citation Analysis]
16 von Toerne C, Laimighofer M, Achenbach P, Beyerlein A, de las Heras Gala T, Krumsiek J, Theis FJ, Ziegler AG, Hauck SM. Peptide serum markers in islet autoantibody-positive children. Diabetologia 2017;60:287-95. [DOI: 10.1007/s00125-016-4150-x] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 2.2] [Reference Citation Analysis]
17 Dekker M, Waissi F, Timmerman N, Silvis MJM, Timmers L, de Kleijn DPV. Extracellular Vesicles in Diagnosing Chronic Coronary Syndromes the Bumpy Road to Clinical Implementation. Int J Mol Sci 2020;21:E9128. [PMID: 33266227 DOI: 10.3390/ijms21239128] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
18 Park HG, Jang KS, Park HM, Song WS, Jeong YY, Ahn DH, Kim SM, Yang YH, Kim YG. MALDI-TOF MS-based total serum protein fingerprinting for liver cancer diagnosis. Analyst 2019;144:2231-8. [PMID: 30849133 DOI: 10.1039/c8an02241k] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
19 Cantor DI, Cheruku HR, Westacott J, Shin JS, Mohamedali A, Ahn SB. Proteomic investigations into resistance in colorectal cancer. Expert Rev Proteomics 2020;17:49-65. [PMID: 31914823 DOI: 10.1080/14789450.2020.1713103] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
20 Lee S, Ju S, Kim SJ, Choi JO, Kim K, Kim D, Jeon ES, Lee C. tipNrich: A Tip-Based N-Terminal Proteome Enrichment Method. Anal Chem 2021;93:14088-98. [PMID: 34615347 DOI: 10.1021/acs.analchem.1c01722] [Reference Citation Analysis]
21 Bank IE, Timmers L, Gijsberts CM, Zhang Y, Mosterd A, Wang J, Chan MY, De Hoog V, Lim SK, Sze SK, Lam CS, De Kleijn DP. The diagnostic and prognostic potential of plasma extracellular vesicles for cardiovascular disease. Expert Review of Molecular Diagnostics 2015;15:1577-88. [DOI: 10.1586/14737159.2015.1109450] [Cited by in Crossref: 29] [Cited by in F6Publishing: 30] [Article Influence: 4.1] [Reference Citation Analysis]
22 Kim S, Choi S, Yoon JH, Kim Y, Lee S, Park T. Drug response prediction model using a hierarchical structural component modeling method. BMC Bioinformatics 2018;19:288. [PMID: 30367591 DOI: 10.1186/s12859-018-2270-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
23 Simon R, Passeron S, Lemoine J, Salvador A. Hydrophilic interaction liquid chromatography as second dimension in multidimensional chromatography with an anionic trapping strategy: application to prostate-specific antigen quantification. J Chromatogr A 2014;1354:75-84. [PMID: 24931446 DOI: 10.1016/j.chroma.2014.05.063] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 1.9] [Reference Citation Analysis]
24 Yeo I, Kim GA, Kim H, Lee JH, Sohn A, Gwak GY, Lee JH, Lim YS, Kim Y. Proteome Multimarker Panel With Multiple Reaction Monitoring-Mass Spectrometry for Early Detection of Hepatocellular Carcinoma. Hepatol Commun 2020;4:753-68. [PMID: 32363324 DOI: 10.1002/hep4.1500] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
25 Song X, Amirkhani A, Wu JX, Pascovici D, Zaw T, Xavier D, Clarke SJ, Molloy MP. Analytical performance of nano-LC-SRM using nondepleted human plasma over an 18-month period. Proteomics 2016;16:2118-27. [PMID: 27233598 DOI: 10.1002/pmic.201500507] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
26 Nicolardi S, Bladergroen MR, Deelder AM, Tollenaar RAEM, Palmblad M, Mesker W, van der Burgt YEM. SPE-MALDI Profiling of Serum Peptides and Proteins by Ultrahigh Resolution FTICR-MS. Chromatographia 2015;78:445-9. [DOI: 10.1007/s10337-014-2812-8] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
27 Lee PY, Chin SF, Low TY, Jamal R. Probing the colorectal cancer proteome for biomarkers: Current status and perspectives. J Proteomics 2018;187:93-105. [PMID: 29953962 DOI: 10.1016/j.jprot.2018.06.014] [Cited by in Crossref: 25] [Cited by in F6Publishing: 26] [Article Influence: 6.3] [Reference Citation Analysis]
28 Yeat NC, Lin C, Sager M, Lin J. Cancer proteomics: developments in technology, clinical use and commercialization. Expert Rev Proteomics 2015;12:391-405. [PMID: 26145529 DOI: 10.1586/14789450.2015.1051969] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
29 Kraus VB, Blanco FJ, Englund M, Henrotin Y, Lohmander LS, Losina E, Önnerfjord P, Persiani S. OARSI Clinical Trials Recommendations: Soluble biomarker assessments in clinical trials in osteoarthritis. Osteoarthritis Cartilage 2015;23:686-97. [PMID: 25952342 DOI: 10.1016/j.joca.2015.03.002] [Cited by in Crossref: 48] [Cited by in F6Publishing: 43] [Article Influence: 8.0] [Reference Citation Analysis]
30 Megger DA, Padden J, Rosowski K, Uszkoreit J, Bracht T, Eisenacher M, Gerges C, Neuhaus H, Schumacher B, Schlaak JF, Sitek B. One Sample, One Shot - Evaluation of sample preparation protocols for the mass spectrometric proteome analysis of human bile fluid without extensive fractionation. Journal of Proteomics 2017;154:13-21. [DOI: 10.1016/j.jprot.2016.11.021] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.2] [Reference Citation Analysis]
31 Percy AJ, Yang J, Chambers AG, Mohammed Y, Miliotis T, Borchers CH. Protocol for Standardizing High-to-Moderate Abundance Protein Biomarker Assessments Through an MRM-with-Standard-Peptides Quantitative Approach. In: Mirzaei H, Carrasco M, editors. Modern Proteomics – Sample Preparation, Analysis and Practical Applications. Cham: Springer International Publishing; 2016. pp. 515-30. [DOI: 10.1007/978-3-319-41448-5_24] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.7] [Reference Citation Analysis]
32 Percy AJ, Mohammed Y, Yang J, Borchers CH. A standardized kit for automated quantitative assessment of candidate protein biomarkers in human plasma. Bioanalysis 2015;7:2991-3004. [DOI: 10.4155/bio.15.222] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 3.3] [Reference Citation Analysis]
33 Noor Z, Ranganathan S. Bioinformatics approaches for improving seminal plasma proteome analysis. Theriogenology 2019;137:43-9. [PMID: 31186128 DOI: 10.1016/j.theriogenology.2019.05.036] [Reference Citation Analysis]
34 Chen YT, Chen HW, Wu CF, Chu LJ, Chiang WF, Wu CC, Yu JS, Tsai CH, Liang KH, Chang YS, Wu M, Ou Yang WT. Development of a Multiplexed Liquid Chromatography Multiple-Reaction-Monitoring Mass Spectrometry (LC-MRM/MS) Method for Evaluation of Salivary Proteins as Oral Cancer Biomarkers. Mol Cell Proteomics 2017;16:799-811. [PMID: 28235782 DOI: 10.1074/mcp.M116.064758] [Cited by in Crossref: 20] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
35 Kim H, Park J, Kim Y, Sohn A, Yeo I, Jong Yu S, Yoon JH, Park T, Kim Y. Serum fibronectin distinguishes the early stages of hepatocellular carcinoma. Sci Rep. 2017;7:9449. [PMID: 28842594 DOI: 10.1038/s41598-017-09691-3] [Cited by in Crossref: 24] [Cited by in F6Publishing: 27] [Article Influence: 4.8] [Reference Citation Analysis]
36 Maes E, Cho WC, Baggerman G. Translating clinical proteomics: the importance of study design. Expert Review of Proteomics 2015;12:217-9. [DOI: 10.1586/14789450.2015.1041512] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
37 Cong Y, Zhang Z, Zhang S, Hu L, Gu J. Quantitative MS analysis of therapeutic mAbs and their glycosylation for pharmacokinetics study. Prot Clin Appl 2016;10:303-14. [DOI: 10.1002/prca.201500098] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 1.4] [Reference Citation Analysis]
38 Lee CW, Chang KP, Chen YY, Liang Y, Hsueh C, Yu JS, Chang YS, Yu CJ. Overexpressed tryptophanyl-tRNA synthetase, an angiostatic protein, enhances oral cancer cell invasiveness. Oncotarget 2015;6:21979-92. [PMID: 26110569 DOI: 10.18632/oncotarget.4273] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 3.3] [Reference Citation Analysis]
39 Mischak H, Critselis E, Hanash S, Gallagher WM, Vlahou A, Ioannidis JP. Epidemiologic design and analysis for proteomic studies: a primer on -omic technologies. Am J Epidemiol. 2015;181:635-647. [PMID: 25792606 DOI: 10.1093/aje/kwu462] [Cited by in Crossref: 28] [Cited by in F6Publishing: 23] [Article Influence: 4.0] [Reference Citation Analysis]
40 Li H, Han J, Pan J, Liu T, Parker CE, Borchers CH. Current trends in quantitative proteomics - an update: Current trends in quantitative proteomics. J Mass Spectrom 2017;52:319-41. [DOI: 10.1002/jms.3932] [Cited by in Crossref: 48] [Cited by in F6Publishing: 38] [Article Influence: 9.6] [Reference Citation Analysis]
41 Hsiao YC, Chu LJ, Chen YT, Chi LM, Chien KY, Chiang WF, Chang YT, Chen SF, Wang WS, Chuang YN, Lin SY, Chien CY, Chang KP, Chang YS, Yu JS. Variability Assessment of 90 Salivary Proteins in Intraday and Interday Samples from Healthy Donors by Multiple Reaction Monitoring-Mass Spectrometry. Proteomics Clin Appl 2018;12. [PMID: 29350471 DOI: 10.1002/prca.201700039] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 2.5] [Reference Citation Analysis]
42 Sobsey CA, Ibrahim S, Richard VR, Gaspar V, Mitsa G, Lacasse V, Zahedi RP, Batist G, Borchers CH. Targeted and Untargeted Proteomics Approaches in Biomarker Development. Proteomics 2020;20:1900029. [DOI: 10.1002/pmic.201900029] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 6.0] [Reference Citation Analysis]
43 Wu HY, Pan YY, Kopylov AT, Zgoda V, Ma MC, Wang CH, Su WC, Lai WW, Cheng PN, Liao PC. Assessment of Serological Early Biomarker Candidates for Lung Adenocarcinoma by using Multiple Reaction Monitoring-Mass Spectrometry. Proteomics Clin Appl 2020;14:e1900095. [PMID: 32012456 DOI: 10.1002/prca.201900095] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
44 Yang J, Roy R, Jedinak A, Moses MA. Mining the Human Proteome: Biomarker Discovery for Human Cancer and Metastases. Cancer J 2015;21:327-36. [PMID: 26222086 DOI: 10.1097/PPO.0000000000000139] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
45 Kim HY, Lee YJ, Kim KB. Analytical method development of methylisothiazolinone, a preservative, in rat plasma using LC-MS/MS. J Chromatogr B Analyt Technol Biomed Life Sci 2018;1100-1101:27-32. [PMID: 30292056 DOI: 10.1016/j.jchromb.2018.09.018] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
46 Camerini S, Mauri P. The role of protein and peptide separation before mass spectrometry analysis in clinical proteomics. J Chromatogr A 2015;1381:1-12. [PMID: 25618357 DOI: 10.1016/j.chroma.2014.12.035] [Cited by in Crossref: 52] [Cited by in F6Publishing: 42] [Article Influence: 6.5] [Reference Citation Analysis]
47 Duangkumpha K, Stoll T, Phetcharaburanin J, Yongvanit P, Thanan R, Techasen A, Namwat N, Khuntikeo N, Chamadol N, Roytrakul S, Mulvenna J, Mohamed A, Shah AK, Hill MM, Loilome W. Discovery and Qualification of Serum Protein Biomarker Candidates for Cholangiocarcinoma Diagnosis. J Proteome Res 2019;18:3305-16. [DOI: 10.1021/acs.jproteome.9b00242] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
48 Kontostathi G, Makridakis M, Zoidakis J, Vlahou A. Applications of multiple reaction monitoring targeted proteomics assays in human plasma. Expert Rev Mol Diagn 2019;19:499-515. [PMID: 31057016 DOI: 10.1080/14737159.2019.1615448] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]